BMP7 activates brown adipose tissue and reduces diet-induced obesity only at subthermoneutrality by Folli, Franco et al.
BMP7 Activates Brown Adipose Tissue and Reduces Diet-
Induced Obesity Only at Subthermoneutrality
Marie¨tte R. Boon1,2*, Sjoerd A. A. van den Berg2,3, Yanan Wang1,2, Jan van den Bossche4,
Sofia Karkampouna5, Matthias Bauwens6, Marijke De Saint-Hubert6, Geertje van der Horst7,
Slobodan Vukicevic8, Menno P. J. de Winther4, Louis M. Havekes1,2,9,10, J. Wouter Jukema2,9,
Jouke T. Tamsma1, Gabri van der Pluijm7, Ko Willems van Dijk2,3, Patrick C. N. Rensen1,2
1Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands, 2 Einthoven Laboratory for Experimental Vascular
Medicine, Leiden University Medical Center, Leiden, The Netherlands, 3Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands,
4Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands, 5Department of Molecular Cell Biology, Leiden University Medical Center,
Leiden, The Netherlands, 6Department of Nuclear Medicine, Maastricht University, Maastricht, The Netherlands, 7Department of Urology, Leiden University Medical
Center, Leiden, The Netherlands, 8Center for Translational and Clinical Research, University of Zagreb, School of Medicine, Zagreb, Croatia, 9Department of Cardiology,
Leiden University Medical Center, Leiden, The Netherlands, 10 TNO-Biosciences, Leiden, The Netherlands
Abstract
Background/Aims: Brown adipose tissue (BAT) dissipates energy stored in triglycerides as heat via the uncoupling protein
UCP-1 and is a promising target to combat hyperlipidemia and obesity. BAT is densely innervated by the sympathetic
nervous system, which increases BAT differentiation and activity upon cold exposure. Recently, Bone Morphogenetic Protein
7 (BMP7) was identified as an inducer of BAT differentiation. We aimed to elucidate the role of sympathetic activation in the
effect of BMP7 on BAT by treating mice with BMP7 at varying ambient temperature, and assessed the therapeutic potential
of BMP7 in combating obesity.
Methods and Results: High-fat diet fed lean C57Bl6/J mice were treated with BMP7 via subcutaneous osmotic minipumps
for 4 weeks at 21uC or 28uC, the latter being a thermoneutral temperature in which sympathetic activation of BAT is largely
diminished. At 21uC, BMP7 increased BAT weight, increased the expression of Ucp1, Cd36 and hormone-sensitive lipase in
BAT, and increased total energy expenditure. BMP7 treatment markedly increased food intake without affecting physical
activity. Despite that, BMP7 diminished white adipose tissue (WAT) mass, accompanied by increased expression of genes
related to intracellular lipolysis in WAT. All these effects were blunted at 28uC. Additionally, BMP7 resulted in extensive
‘browning’ of WAT, as evidenced by increased expression of BAT markers and the appearance of whole clusters of brown
adipocytes via immunohistochemistry, independent of environmental temperature. Treatment of diet-induced obese
C57Bl6/J mice with BMP7 led to an improved metabolic phenotype, consisting of a decreased fat mass and liver lipids as
well as attenuated dyslipidemia and hyperglycemia.
Conclusion: Together, these data show that BMP7-mediated recruitment and activation of BAT only occurs at
subthermoneutral temperature, and is thus likely dependent on sympathetic activation of BAT, and that BMP7 may be a
promising tool to combat obesity and associated disorders.
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Introduction
Human adipose tissue is broadly classified as either white
adipose tissue (WAT) or brown adipose tissue (BAT). WAT
functions as an energy storage depot characterized by a large
intracellular lipid droplet per adipocyte and is furthermore a
prominent endocrine organ, producing hormones that regulate
appetite and satiety [1]. In contrast, BAT is an energy dissipation
depot characterized by multi-locular lipid droplets per adipocyte
and a wealth of densely packed mitochondria. Uncoupling
protein-1 (UCP-1) in these mitochondria uncouples respiration
from ATP synthesis, leading to heat production [2].
The most well-known trigger for activation of BAT is cold,
which increases sympathetic outflow from the hypothalamic
temperature centre towards BAT, leading to release of noradren-
alin and increased thermogenesis. Recently, a second alternative
pathway was demonstrated to control thermogenesis, in which
alternatively activated (M2) macrophages release noradrenalin to
activate BAT locally [3].
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Fatty acids are an important substrate for BAT thermogenesis.
The fatty acids originate from triglyceride (TG)-rich lipoproteins
and are released upon local lipoprotein lipase (LPL) activity [4].
Mouse studies have shown that BAT has a great clearance
capacity for TG. Cold exposure drastically accelerates plasma TG
clearance as a result of increased uptake into BAT and thereby
corrects hyperlipidemia in pathophysiological settings [5].
The recent findings that metabolically active BAT stores exist in
adult humans and that BAT volume and activity are lower in
obese subjects [6–8], have increased interest in the therapeutic
potential of BAT to combat obesity and related disorders, such as
dyslipidemia. In both rodents and humans, brown adipocytes are
present in well-localized fat pads, called ‘constitutive BAT’, as well
as scattered in other tissues, such as WAT and muscle, there
forming a ‘peripheral’ pool of brown adipocytes [9]. The brown
adipocytes in WAT are also called ‘brite’ cells because their
phenotypic characteristics lie between those of white and brown
adipocytes [10]. Though in mice it has been demonstrated that a
clear phenotypic distinction exists between adipocytes derived
from constitutive BAT depots and brite cells, in humans this is still
under debate. One recent study in which human brown fat
biopsies were genotyped showed that this brown fat was more
resembling the beige fat found in rodent white fat depots rather
than the classical brown fat [11]. In contrast, another study
showed that although the properties of human brown fat varied
substantially between individuals, some human samples did have
similarities with rodent constitutive BAT [12]. Thus, although it is
clear that human adults possess metabolically active BAT stores,
the precise composition as well as the stimuli that induce its
formation remain to be determined. Identification of signalling
pathways that regulate differentiation of the two types of brown
adipocytes could lead to the development of novel therapies for
obesity and related disorders.
Bone Morphogenetic Protein 7 (BMP7) is an important inducer
of brown adipocyte differentiation. In vitro treatment of a variety of
precursor cells, such as C3H10T1/2 mesenchymal cells and
Myf5+ precursor cells, with BMP7 resulted in the development of
fully differentiated brown adipocytes with high UCP-1 expression
[13,14]. Moreover, short-term adenoviral overexpression of BMP7
in different mouse models confirmed the ability of BMP7 to
increase interscapular brown fat mass and oxygen consumption
[13]. However, the potential of BMP7 to induce BAT activity in a
more therapeutic regimen is currently unknown. Moreover, the
role of sympathetic activation in the effects of BMP7 on brown fat
function and energy metabolism, and the therapeutic potential of
BMP7 to treat dyslipidemia and obesity has not been reported yet.
Therefore, the aim of the present study was to elucidate the role
of ambient temperature, which determines the sympathetic output
to BAT, in the effect of BMP7 on BAT and to asses the therapeutic
potential of BMP7 in combating obesity and related disorders. We
show here that treatment of C57Bl6/J mice with BMP7 via
osmotic minipumps for 4 weeks effectively increased BAT
differentiation, BAT activity and total energy expenditure, and
decreased white fat mass. These effects were blunted at 28uC
(thermoneutral temperature) and are thus likely dependent on the
degree of sympathetic activation. Furthermore, BMP7 markedly
enhanced brite cell formation in WAT independent of environ-
mental temperature. Of note, treatment of diet-induced obese
C57Bl6/J mice with BMP7 diminished fat mass and liver lipid
content and attenuated dyslipidemia and hyperglycemia. Togeth-
er, our results show that low subthermoneutral ambient temper-
ature, at which sympathetic activation is present, is required for
BMP7-mediated recruitment and activation of BAT and suggest
that BMP7 may be a therapeutic tool to ameliorate obesity, and
related disorders.
Research Design and Methods
Animals
Male C57Bl/6J mice (Jackson Laboratory, Bar Harbor, ME)
were housed in conventional cages with a 12:12-h light-dark cycle
and had free access to food and water. All animal experiments
were approved by the institutional ethics committee on animal
care and experimentation at Leiden University Medical Center.
Mechanistic studies on the effect of BMP7 on BAT. 4-
week old C57Bl/6J mice were randomized according to their body
weight and plasma triglyceride (TG) and total cholesterol (TC)
levels into 6 groups (n = 9). Mice were housed at 21uC or at 28uC
(i.e. thermoneutral temperature) and received soluble recombinant
BMP7 (obtained from the Vukicevic lab, Zagreb, Croatia) (33 mg/
kg/day or 100 mg/kg/day) or vehicle (saline) for 4 weeks while
being fed a high-fat diet (D12451, Research Diet Services, which
contains 4.73 kcal/gram diet and 45% of kcal as fat, 35% as
carbohydrate and 20% as protein). BMP7 or saline was
administered at a constant rate via an osmotic minipump (model
1004, Alzet DURECT Corp), which was implanted subcutane-
ously in the left back region. Mice were weighed twice a week and
food intake was measured every other day by weighing the food
that was left on the racks.
18F-FDG PET Scans
After 7 days of treatment, mice underwent an 18F-fluorodeox-
yglucose (FDG) positron emission tomography (PET) scan to
quantify the metabolic volume of different BAT depots (interscap-
ular, neck and back). After 2 h fasting, mice were anesthetized
using isoflurane and i.p. injected with 18F-FDG (20 MBq). Then,
mice were allowed to awake, and were placed in their cage for 1 h
(phase of tracer uptake). Scans were performed with the microPET
system (uPET Focus 120, Siemens). Data for accumulation of 18F-
FDG on the PET images were determined on the basis of
radioactive counts per volume, corrected for the injected dose per
gram of animal weight. A volume of interest was manually drawn
around the different BAT depots, with a cut-off value of 50% of
the maximum inside the volume, to determine BAT metabolic
volume.
Indirect Calorimetry
Indirect calorimetry was performed in fully automatic metabolic
cages (LabMaster System, TSE Systems, Bad Homburg, Ger-
many) during the fourth week of treatment. After 20 h acclima-
tization, oxygen uptake (V˙ O2), carbon dioxide production (V˙
CO2) and caloric intake were measured for 5 consecutive days.
Carbohydrate and fat oxidation rates were calculated from V˙ O2
and V˙ CO2 as described previously [15]. Total energy expendi-
ture (EE) was calculated from the sum of carbohydrate and fat
oxidation. Physical activity was measured using infrared sensor
frames.
RNA Isolation and Q-RT-PCR Analysis
Total RNA was isolated with the NucleospinH RNA II Kit
(Macherey-Nagel) according to the manufacturer’s instructions.
1 mg of total RNA was reverse-transcribed with iScript cDNA
synthesis kit (Bio-Rad), and the obtained cDNA was purified with
Nucleospin Extract II kit (Macherey-Nagel). Real-time PCR was
carried out on the IQ5 PCR machine (Bio-Rad) using the
Sensimix SYBR Green RT-PCR mix (Quantace). Melt curve
analysis was included to assure a single PCR product was formed.
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Expression levels were normalized using ß2-microglobulin and 36b4
as housekeeping genes. Primer sequences are listed in Table 1.
Histology
Interscapular BAT and gonadal WAT were removed and
fixed directly in 4% paraformaldehyde, dehydrated and
embedded in paraffin. Sections (5 mm) were dewaxed in xylene,
rehydrated in ethanol and treated with 3% H2O2 (Sigma) in
absolute methanol for 30 min. Next, sections were immersed in
10 mM citrate buffer (pH = 6.0), boiled for 10 min and cooled
down at room temperature. Slides were blocked during 60 min
with normal goat serum (1:75 in PBS) and incubated overnight
at 4uC with rabbit monoclonal anti-UCP-1 antibodies (Abcam)
diluted 1:300 in normal goat serum (1:75). Next, sections were
incubated for 60 min with biotinylated goat a-rabbit secondary
antibodies (Vector Labs) diluted 1:600 in normal goat serum
(1:75). Immunostaining was amplified using Vector Laboratories
Elite ABC kit (Vector Labs) and the immunoperoxidase
complex was visualized with Nova Red (Vector Labs).
Counterstaining was performed with Mayer’s hematoxylin (1:4).
Isolation of Peritoneal Macrophages
Mouse peritoneal cells were collected by flushing the peritoneal
cavity with 10 ml sterile ice-cold PBS, as previously described [16].
Cells were centrifuged at 1,200 rpm for 5 min at 4uC and
resuspended in RPMI1640 medium supplemented with 10% heat-
inactivated fecal calf serum. Total leukocyte counts were
determined using a Beckman Counter. Cells were plated overnight
at 16106 cells/ml in 500 ml in a 24 wells plate. Cells were
subsequently lysed in buffer with b-mercaptoethanol (100:1) and
RNA was isolated as described above.
Studies on BMP7 in a diet-induced obesity model. 8-
week old C57Bl/6J mice were fed a high-fat diet (45% energy,
D12451, Research Diet Services) for 12 weeks to induce obesity.
Mice were then randomized according to their body weight and
plasma TG, TC and glucose levels into groups that received
soluble recombinant BMP7 (100 mg/kg/day) or vehicle (saline)
for 4 weeks via subcutaneous osmotic minipumps while being
fed a high-fat diet. Mice were weighed twice a week and during
the fourth week of treatment, mice were house in fully
automatic metabolic cages as described under ‘Indirect calo-
rimetry’.
Dual-energy X-ray Absorptiometry (DEXA) Scan
After 4 weeks treatment, body composition was measured by
DEXA using the Norland pDEXA Sabre X-ray Bone Densitom-
eter. Mice were anaesthetized intraperitoneally with a combina-
tion of 6.25 mg/kg acepromazine (Alfasan), 6.25 mg/kg mid-
azolam (Roche) and 0.31 mg/kg fentanyl (Janssen-Cilag). The
total body of the mice was scanned, yet the heads were excluded
from the analyses.
Plasma Parameters
At baseline and after 4 weeks of treatment, plasma was obtained
via tail vein bleeding after 4 h fasting and assayed for TC, TG,
and phospholipids using the commercially available enzymatic kits
from Roche Molecular Biochemicals. Plasma glucose levels were
measured using a commercially available kit and standardized
according to the instructions of the manufacturer (Instruchemie,
Delfzijl, The Netherlands).
Liver Lipid Extraction
Lipids were extracted from livers consistent with a modified
protocol from Bligh and Dyer [17]. In short, a small piece of liver
was homogenized in ice-cold methanol. Lipids were removed after
centrifugation by adding 1,800 ml of CH3OH-CHCl3 (3:1 vol/vol)
to 45 ml of homogenate. The CHCl3 phase was dried and
suspended in 2% Triton X-100. Hepatic triglyceride (TG), total
cholesterol (TC) and phospholipid (PL) concentrations were
measured using commercial kits, as explained above. Liver lipids
were expressed per milligram of protein, which was determined
using the BCA protein assay kit (Pierce).
Table 1. Primers used for quantitative real-time PCR analysis.
Gene Forward primer Reverse primer
36b4 GGACCCGAGAAGACCTCCTT GCACATCACTCAGAATTTCAATGG
Arg1 CATGGGCAACCTGTGTCCTT CGATGTCTTTGGCAGATATGCA
Atgl ACAGTGTCCCCATTCTCAGG TTGGTTCAGTAGGCCATTCC
B2-microglobulin TGACCGGCTTGTATGCTATC CAGTGTGAGCCAGGATATAG
Ccl5 GGAGTATTTCTACACCAGCAGCAA GCGGTTCCTTCGAGTGACA
Cd163 CTCAGGAAACCAATCCCAGA CAAGAGCCCTCGTGGTAGAC
Cd36 GCAAAGAACAGCAGCAAAATC CAGTGAAGGCTCAAAGATGG
Hsl AGACACCAGCCAACGGATAC ATCACCCTCGAAGAAGAGCA
Il10 TTTGAATTCCCTGGGTGAGAA CTCCACTGCCTTGCTCTTATTTTC
Mrc1 GAGAGCCAAGCCATGAGAAC GTCTGCACCCTCCGGTACTA
Nos2 CGGGCATCTGGTAGCCAGCG TGGCAACATCAGGTCGGCCAT
Soc1 CCGTGGGTCGCGAGAAC AAGGAACTCAGGTAGTCACGGAGTA
Tnf GGCAGGTCTACTTTGGAGTCATTGC ACATTCGAGGCTCCAGTGAATTCGG
Ucp1 TCAGGATTGGCCTCTACGAC TGCATTCTGACCTTCACGAC
Arg1, arginase 1; Atgl, adipose triglyceride lipase; Ccl5, Chemokine (C–C motif) ligand 5;
Hsl, hormone-sensitive lipase; Il10, interleukin-10; Mrc1, mannose receptor 1; Nos2,
nitric oxide synthase 2; Tnf, tumor necrosis factor-a Ucp-1,uncoupling protein-1.
doi:10.1371/journal.pone.0074083.t001
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Figure 1. Systemic administration of BMP7 increases BAT volume and UCP-1 expression in mice at 216C, but not at
thermoneutrality. 4-week-old male C57Bl/6J mice were treated for 4 weeks with BMP7 (33 or 100 mg/kg/day) or saline via a subcutaneously
located osmotic minipump at an environmental temperature of 21uC or 28uC while feeding a high-fat diet (45% fat). (A) Weight of the interscapular
brown fat pads, after quantitative removal, of mice housed at 21uC (left) and 28uC (right). (B) Representative pictures of 18F-FDG PET scans that were
BMP7 Activates Brown Fat Only at 21 Degrees
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In vitro Treatment of Bone-marrow Derived Macrophages
with BMP7
Bone marrow-derived macrophages were obtained from the
hind limbs of C57Bl6/J mice as described previously [16,18]. All
muscle tissue was removed from the bones and the bones were
placed in a petri-dish filled with ice-cold sterile PBS, 70% ethanol
(30 sec) and then again ice-cold PBS. The femur and tibia were
cut at both ends and the bones were flushed through with ice-cold
sterile PBS after which the bone marrow was collected. Then, cells
were rinsed with PBS, lifted with a warm Lidocain/EDTA/PBS
solution, washed in RPMI1640 and plated in LCM at 106 cells/ml
in 500 ml in a 24 wells plate for 8 days. At day 9, cells were either
stimulated with soluble recombinant BMP7 (8.3 nM) or vehicle for
24 hours or with BMP7 or vehicle for 18 hours +6 hours LPS
treatment (10 ng/ml). The supernatant was collected for mea-
surement of IL-6, IL-12 and TNF by commercial ELISA
(Invitrogen) and NO2
- by Griess assay (Invitrogen), according to
the manufacturer’s instructions. RNA was isolated with the Roche
RNA isolation kit as described by the suppliers.
Statistical Analysis
All data are represented as means 6 SEM unless indicated
otherwise. Data were analyzed with SPSS 17.0 using one-way
ANOVA (when three groups were compared) Student T-tests
(when two groups were compared) or, in case the data were not
normally distributed, using nonparametric tests. Statistical analysis
for the indirect calorimetry data were performed on 12-hour
averages per parameter, based on the light-dark cycle. Data were
generated for the light period between 7:00 AM and 7:00 PM and
for the dark period between 7:00 PM and 7:00 AM. Normality
checks were performed and comparisons were made using either
one-way ANOVA or nonparametric tests. Probability values less
than 0.05 were considered statistically significant.
Results
BMP7 Increases BAT Volume and UCP-1 Expression at
21uC, but not at Thermoneutrality
To investigate whether BMP7 administered via constant low-
dose release by osmotic minipumps is capable of increasing BAT
volume and activity in vivo, 4-week old C57Bl6/J mice (n = 9 per
group) were treated with BMP7 at 33 mg/kg/day, 100 mg/kg/day
or saline for 4 weeks. Mice were housed at either 21uC or 28uC,
the latter being a thermoneutral temperature at which sympathetic
activity towards BAT is virtually absent [19]. At 21uC, BMP7
significantly and dose-dependently increased interscapular BAT
weight, both at 33 mg/kg/day (+20%, P,0.05) and at 100 mg/kg/
day (+30%, P,0.001), while at 28uC no effects of BMP7 were seen
(Fig. 1A). 18F-FDG PET-scans acquired one week after BMP7
treatment (100 mg/kg/day) in mice that were housed at 21uC,
showed that BAT metabolic volume in the neck region had
already increased by +175% (P,0.001, Fig. 1B–C). Furthermore,
100 mg/kg/day of BMP7 increased expression of Ucp1 in BAT as
measured by qPCR (+115%, P,0.05, Fig. 1D) and increased
UCP-1 protein judged from immunohistochemistry (Fig. 1E). At
28uC, expression of Ucp1 was markedly downregulated compared
to 21uC (297%, P,0.001), consistent with virtually absent
sympathetic activity (Fig. 1D). Moreover, lipid droplet size was
markedly increased, pointing to less active BAT (Fig. 1E).
Importantly, at 28uC the effect of BMP7 on Ucp1 expression
was completely abolished (Figs. 1D–E).
BMP7 Dose-dependently Increases Energy Expenditure,
Related to Increased Fat Oxidation at 21uC, but not at
Thermoneutrality
After three weeks of treatment with BMP7, whole body energy
metabolism and food intake of mice was assessed with a metabolic
cage system. At 21uC, BMP7 significantly and dose-dependently
increased energy expenditure, fatty acid and carbohydrate
oxidation (up to +45%, +37% and +26% respectively, P,0.05),
while physical activity levels were unaltered (Fig. 2A). Because
fatty acid and carbohydrate oxidation were both increased,
respiratory exchange ratio did not change upon BMP7 treatment
(data not shown). Of note, BMP7 treatment resulted in a marked
increase in food intake, both at 33 mg/kg/day (+28%, P,0.05)
and at 100 mg/kg/day (+37%, P,0.01) (Fig. 2B). At 28uC, total
energy expenditure (224%), fatty acid (238%) and carbohydrate
oxidation (213%) as well as food intake (215%) were significantly
lower compared to 21uC and the effects of BMP7 were fully absent
(Fig. S1A–B). As fatty acids are an important substrate for energy
expenditure in BAT, we determined the expression of the
scavenger receptor Cd36, hormone-sensitive lipase (Hsl), and
adipose triglyceride lipase (Atgl), the latter two involved in
intracellular lipolysis. At 21uC, BMP7 increased expression of
Cd36 (up to +95%, P,0.05, Fig. 2C) and Hsl (up to +82%,
P,0.05, Fig. 2D) but not of Atgl (Fig. 2E) in BAT, suggesting
increased cellular uptake of fatty acids via CD36 and liberation of
intracellular fatty acids from TG via HSL for oxidation purposes.
At 28uC, basal expression of Cd36, Hsl and Atgl was lower and
unaffected by BMP7 (Figs. 2C–E).
BMP7 Decreases Gonadal White Fat Weight and Increases
Expression of Genes Related to Lipolysis at 21uC, but not
at Thermoneutrality
Despite the increased energy expenditure, BMP7 treatment did
not affect body weight development, not at thermoneutrality (Fig.
S1C) nor at 21uC (Fig. S2A). This might in part be explained by an
increase in bone mineral content induced by BMP7 treatment
(+20%, P,0.05) (Fig. S2B), a well-known effect of BMP7 [20]. Of
note, mice that were housed at thermoneutrality gained signifi-
cantly more body weight compared to mice housed at ambient
temperature (+25% vs +14%, P,0.05). To investigate whether
BMP7 treatment affected white fat content in vivo, we quantita-
tively removed and weighed the right gonadal white fat pad
(gWAT). In line with our calorimetric data (Fig. 2A), BMP7
decreased gWAT weight at 21uC (212%, P,0.05), but not at
28uC (Fig. 3A). To gain more insight into the underlying
mechanism, we studied expression of genes related to lipolysis in
this fat pad. Indeed, BMP7 increased gene expression of both Hsl
(+150%, P,0.05, Fig. 3B) and Atgl (+50%, P,0.05, Fig. 3C) at
21uC, suggesting increased TG breakdown in WAT, but not at
28uC.
taken in control and BMP7 (100 mg/kg/day) treated animals (housed at 21uC) after one week of treatment, from which BAT metabolic volume (C) was
determined. Arrows indicate neck BAT depots. (D) Expression of Ucp1 in BAT measured by Q-RT-PCR of mice housed at 21uC (left) and 28uC (right). (E)
Representative pictures of immunohistochemical UCP-1 stainings of BAT in control and BMP7 (100 mg/kg/day) treated animals housed at 21uC (top)
and 28uC (bottom). Pink staining represents UCP-1 protein. Magnification 100x. Scale bar, 100 mm. Values are means+SEM (n= 9) and expression of
genes was corrected for the housekeeping genes b2-microglobulin and 36b4. *P,0.05, ***P,0.001 compared to the control group.
doi:10.1371/journal.pone.0074083.g001
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Figure 2. BMP7 increases energy expenditure and fat oxidation at 216C. 4-week-old male C57Bl/6J mice were treated for 4 weeks with
BMP7 (33 or 100 mg/kg/day) or saline via a subcutaneously located osmotic minipump at an environmental temperature of 21uC or 28uC while
feeding a high-fat diet (45% fat). (A) Energy expenditure, activity levels and fat and carbohydrate oxidation measured during 5 consecutive days in the
fourth week of treatment via fully automatic metabolic cages in mice housed at 21uC. Measurements were corrected for free fat mass (FFM) (B) Food
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BMP7 Induces Brite Cell Formation Independent of
Environmental Temperature
In WAT, brite cells are present that contribute to total energy
expenditure through uncoupling by UCP-1 [21]. Therefore, we
studied if BMP7 treatment induced brite cell formation. Indeed,
BMP7 markedly increased UCP-1 expression in gWAT, both at
21uC (+920%, P,0.05) and 28uC (+760%, P,0.05) (Fig. 3D).
Moreover, immunohistochemical staining of UCP-1 in gWAT
confirmed that, at both temperatures, BMP7 induced the
appearance of fields of UCP-1 positive cells with brown cell-like
morphology, so-called ‘browning’ of white fat (Fig. 3E).
BMP7 Alters M1/M2 Balance in BAT and WAT at 21uC, but
not at Thermoneutrality
Recently, M2 macrophages were shown to be crucial for BAT
function via release of noradrenalin [3]. Recruitment and
activation of these macrophages is induced by sympathetic
stimulation of BAT [3]. Therefore, we investigated whether
BMP7 could influence the presence of M2 macrophages in BAT,
thereby possibly contributing to BMP7-induced BAT activation.
Indeed, after 4 weeks of BMP7 treatment, expression of the M2
markers Mrc1 tended to and Cd163 was increased in BAT (+94%,
P = 0.068 and +232%, P,0.05 respectively) (Fig. 4A–B), while the
M1 markers Nos2 and Tnf (Fig. 4C–D) were unaltered. Interest-
ingly, at 28uC, basal expression of all tested macrophage markers
was largely diminished, which is in line with diminished
sympathetic activation, and expression was not influenced by
BMP7 treatment (Fig. 4B,D). Moreover, mice that received BMP7
treatment showed increased expression of M2 markers in gWAT,
but only at 21uC (Figs. S3A–C). In addition, isolated peritoneal
macrophages from mice that had been treated with BMP7
(100 mg/kg/day) at 21uC showed increased expression of the M2
markers Mrc1 and Cd163, while expression of the M1 markers Tnf
and Nos2 was markedly diminished (Fig. 4E). Thus, both in the
adipose tissue and in the peritoneal cavity, the M1/M2 balance
was altered towards M2 after in vivo BMP7 treatment at 21uC.
To investigate whether BMP7 directly affects macrophage
polarisation, we treated bone-marrow derived macrophages with
BMP7 for 24 h in vitro. However, no effect was seen on expression
of M1 or M2 markers as measured via Q-RT-PCR (Fig. 4F), nor
on cytokine production by macrophages after stimulation with
LPS (Figs. S4A–D), suggesting that BMP7 alters M1/M2 balance
in vivo via an indirect mechanism.
BMP7 Decreases Obesity and Attenuates Liver Lipid
Accumulation, Dyslipidemia, and Hyperglycemia in Diet-
induced Obese Mice
To investigate if BMP7 could improve the metabolic phenotype
in diet-induced obesity, C57Bl6/J mice were fed a high-fat diet for
12 weeks and then treated with BMP7 (100 mg/kg/day) or saline
for four weeks via subcutaneous osmotic minipumps in the
presence of a high-fat diet. After 4 weeks of treatment, BMP7
tended to decrease body weight (27%, P = 0.09) (Fig. 5A) but
significantly reduced total fat mass (27%, P,0.05) as measured by
DEXA analysis (Fig. 5B). Furthermore, BMP7 increased total
energy expenditure (+28%, P,0.05) (Fig. 5C). In liver, BMP7
markedly reduced triglyceride (TG) accumulation (240%,
P,0.01) as well as phospholipids (221%, P,0.05), but not total
cholesterol (TC) (Fig. 5D). In addition, BMP7 lowered plasma TG
(225%, P,0.05) and total cholesterol levels (210%, P,0.05)
(Fig. 5E), and diminished hyperglycemia (227%, P,0.01).
Overall, these data are in full accordance with increased fatty
acid and carbohydrate oxidation induced by BMP7 treatment and
underscore the therapeutic potential of BMP7 to diminish diet-
induced obesity and related disorders.
Discussion
In this study, we show that 4 weeks treatment of mice with the
endogenous growth factor BMP7 effectively increased BAT
volume and formation of brite cells in WAT and boosted whole-
body metabolism. We furthermore demonstrate that at thermo-
neutral temperature nearly all effects of BMP7 on BAT were
absent, suggesting that sympathetic activation at least in part
contributes to the effect of BMP7 on BAT differentiation and
activity. Moreover, BMP7 was able to diminish white fat content,
liver lipid accumulation as well as to reduce dyslipidemia and
hyperglycemia in diet-induced obese mice, underscoring the
therapeutic potential of BMP7 in combating obesity and related
disorders.
Our data are in line with a previous study performed by Tseng
et al. [13], in which transient adenoviral overexpression of BMP7
increased BAT volume and oxygen consumption. We show that
BMP7 markedly stimulates BAT volume and activity in mice only
at subthermoneutral temperature, accompanied by a reduction in
diet-induced obesity, liver lipid accumulation, dyslipidemia and
hyperglycemia, and an altering of the M1/M2 balance in BAT
and WAT towards increased anti-inflammatory M2 macrophages.
Interestingly, we found that treating mice for 4 weeks with
BMP7 not only diminished white fat content in diet-induced obese
mice, but also markedly lowered liver lipid accumulation, plasma
TG levels and, to a lesser extent, plasma cholesterol levels. The
lowering in plasma lipid levels is probably the direct consequence
of the increased BAT activity induced by BMP7. That is, fatty
acids derived from LPL-mediated hydrolysis of TG-rich lipopro-
teins form an important substrate for BAT thermogenesis [2].
Indeed, expression of CD36 in BAT, a scavenger receptor that is
rate-limiting for the uptake of fatty acids from plasma into BAT
[22], was significantly upregulated in BAT of BMP7 treated mice.
Moreover, a recent study by Bartelt et al. [5] shows that BAT has
a tremendous capacity to clear plasma TG. 4 h of cold induction
(4uC) normalized plasma TG levels in severely hypertriglyceride-
mic apoA5 knock-out mice [5]. Since increased plasma TG levels
are an independent risk factor for cardiovascular disease in both
men and women [23] BMP7 might thus be an interesting
treatment modality to manage cardiovascular disease through
attenuating dyslipidemia via targeting BAT.
Despite an improved metabolic phenotype in both lean and
diet-induced obese mice upon BMP7 treatment, we did not
observe effects on body weight development. This might in part be
due to the fact that BMP7 is capable of inducing bone formation
[20]. Indeed, in our study, BMP7 treated mice exhibited increased
bone mineral content as measured via DEXA-scan. In addition,
part of the beneficial effect of BMP7 on energy expenditure might
be offset by the increase in food intake (up to +37%) we observed.
This is probably rather a consequence of the increased uncoupling
due to BAT activation [24] then a direct effect of BMP7 on food
intake measured during the fourth week of treatment in mice housed at 21uC. (C–E) Expression of Cd36 (C), Hsl (D) and Atgl (E) in BAT measured by Q-
RT-PCR of mice housed at 21uC (left) or 28uC (right). Values are means+SEM (n= 9) and expression of genes was corrected for the housekeeping genes
b2-microglobulin and 36b4. *P,0.05, **P,0.01 compared to the control group.
doi:10.1371/journal.pone.0074083.g002
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Figure 3. BMP7 reduces white fat weight and induces browning of white adipose tissue. 4-week-old male C57Bl/6J mice were treated for
4 weeks with BMP7 (33 or 100 mg/kg/day) or saline via a subcutaneously located osmotic minipump at an environmental temperature of 21uC or 28uC
while feeding a high-fat diet (45% fat). (A) Weight of the right gonadal white fat pad, after quantitative removal, after which expression of Hsl (B), Atgl
(C) and Ucp1 (D) was measured by Q-RT-PCR of mice housed at 21uC (left) or 28uC (right). (E) Representative pictures of immunohistochemical UCP-1
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stainings of WAT in the control and BMP7 (100 mg/kg/day) animals housed at 21uC (top) and 28uC (bottom). Pink staining represents UCP-1 protein.
Black arrows point to UCP-1 positive areas. Magnification 100x. Scale bar, 100 mm. Values are means+SEM (n= 9) and expression of genes was
corrected for the housekeeping genes b2-microglobulin and 36b4. *P,0.05 compared to the control group.
doi:10.1371/journal.pone.0074083.g003
Figure 4. BMP7 results in altered M1/M2 balance in BAT and peritoneal macrophages. 4-week-old male C57Bl/6J mice were treated for 4
weeks with BMP7 (33 or 100 mg/kg/day) or saline via a subcutaneously located osmotic minipump at an environmental temperature of 21uC or 28uC
while feeding a high-fat diet (45% fat). Expression of the M2 markers Mrc1 (A) and Cd163 (B) and the M1 markers Nos2 (C) and Tnf (D) was measured in
BAT by Q-RT-PCR of mice housed at 21uC (left) and 28uC (right). (E) After 4 weeks of treatment, peritoneal macrophages were isolated and markers of
M2 and M1 macrophages were measured by Q-RT-PCR of mice housed at 21uC. (F) Bone-marrow derived macrophages were isolated from untreated
C57Bl/6J mice and treated ex vivo with BMP7 (8.3 nM) for 24 hrs. The expression of markers for M2 and M1 macrophages was measured via Q-RT-PCR.
Values are means+SEM (n= 9 for in vivo and n= 3 for in vitro) and expression of genes was corrected for the housekeeping genes b2-microglobulin
and 36b4. *P,0.05 compared to the control group.
doi:10.1371/journal.pone.0074083.g004
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intake, since we did not observe this effect at thermoneutrality.
Moreover, a recent study by Townsend et al [25] showed that
intracerebral infusion of BMP7 resulted in a decrease in food
intake rather than an increase.
A striking finding in our study is that at thermoneutrality, BMP7
exerted virtually no effect on BAT, suggesting that sympathetic
activation of BAT is a prerequisite for the effects of BMP7 on BAT
differentiation and activity.
Figure 5. BMP7 decreases obesity and attenuates liver lipid accumulation, dyslipidemia and hyperglycemia in diet-induced obese
mice. 8-week-old male C57Bl/6J mice were fed a high-fat diet (45% fat) for 12 weeks and then treated for 4 weeks with BMP7 (100 mg/kg/day) or
saline via a subcutaneous osmotic minipump at an environmental temperature of 21uC while feeding a high-fat diet (A) Body weight development
(gram) (B) Total fat mass as measured via DEXA-scan (expressed as percentage of body weight) (C) Energy expenditure measured during 5
consecutive days in the fourth week of treatment via fully automatic metabolic cages (D) Liver content of triglycerides (TG), total cholesterol (TC) and
phospholipids (PL) (E) Plasma triglyceride (TG) and total cholesterol (TC) levels. (F) Plasma glucose levels. Values are means+SEM (n= 9). *P,0.05,
**P,0.01 compared to the control group.
doi:10.1371/journal.pone.0074083.g005
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A first explanatory mechanism for this finding may involve the
intracellular signaling route by which BMP7 induces UCP-1
upregulation in brown adipocytes. The pathway involves binding
of BMP7 to the BMP-receptor II subtype and induction of the p38
MAPK route. This results, via activation of still unknown
transcription factors, in upregulation of UCP-1 expression
[26,27]. Interestingly, the b3-adrenergic signaling route, which is
induced upon sympathetic activation of BAT, also induces the p38
MAPK route, though via protein kinase A (PKA) activation [27].
Thus, via p38 MAPK, the b3-adrenergic and BMP7 signaling
routes are intertwined. Possibly, a certain degree of p38 MAPK
activity is essential for the BMP7 signaling route to induce its
downstream effects on UCP-1 expression. This might explain why
at thermoneutrality, in which sympathetic activity and thus b3
signalling towards BAT are largely diminished, BMP7 was unable
to increase BAT volume and activity.
A second mechanism that could explain the ineffectiveness of
BMP7 at thermoneutral temperature may involve a central mode
of action of BMP7. A central player involved in BAT activation is
the hypothalamus, which projects onto sympathetic nerves that
densely innervate BAT [2]. Various circulating peptides have been
shown to be capable of activating BAT via the hypothalamus, such
as GLP-1 [28] and BMP8B, another member of the BMP family
[29]. In addition, Townsend et al. [25] showed that central
administration of BMP7 resulted in reduced food intake,
confirming that BMP7 is at least capable of exerting central
effects. However, it remains to be determined whether subcuta-
neously administered BMP7 is able to enter the hypothalamus to
subsequently exert central actions. The absence of effect of BMP7
at thermoneutral temperature can then be explained by largely
reduced sympathetic output towards BAT.
Interestingly, we showed that treatment of mice with BMP7
resulted in an altered M1/M2 macrophage balance in both BAT,
gWAT and the peritoneal cavity, with increased expression of M2
markers. M2 macrophages have recently been shown to impor-
tantly contribute to BAT thermogenesis by releasing noradrenalin
[3]. Possibly the increased presence of M2 macrophages in BAT in
response to BMP7 treatment contributed to the increased BAT
activity found in these mice. However, since the initial paper
describing the involvement of M2 macrophages in BAT function
has been under debate recently, future studies should further
explore the necessity of M2 macrophages in mediating the effects
of BMP7 on BAT. Furthermore, whether the effect of BMP7 on
macrophage polarisation is either direct or indirect, in response to
changes in BAT, remains to be determined. Although we could
not show in our in vitro experiments a direct effect of BMP7 on
M1/M2 skewing in bone-marrow derived macrophages, a recent
study in which human THP-1 monocytes were treated with BMP7
demonstrated significant polarization of monocytes into M2
macrophages [30]. However, since the change in M1/M2 balance
did not happen at thermoneutral temperature suggests that
environmental factors are at least in part involved in the effects
of BMP7 on macrophage polarisation.
In this study, we show that BMP7 not only increased the volume
of the interscapular brown fat pad, but also show for the first time
that BMP7 markedly induced appearance of brite cells in WAT,
so-called ‘browning’ of WAT. This could have been caused by
either transdifferentiation of white fat cells into brite adipocytes, or
differentiation of brite precursor cells that are present in WAT
towards brite adipocytes. Both mechanisms are plausible. White
fat cells have been shown to be capable of transdifferentiating
towards brite adipocytes and they furthermore have the BMP-II
receptor [21,31]. Moreover, in WAT, Myf5- precursor cells are
present that can differentiate into brite cells in vitro [9,32]. Future
studies are needed to elucidate the mechanism by which BMP7
induces ‘browning’ of WAT in more detail. However, since we
found that brown fat cells obviously appeared as clusters in WAT,
it is more plausible that BMP7 primarily acted on precursor cells
resulting in proliferation and subsequent differentiation. Intrigu-
ingly, browning happened independent of environmental temper-
ature. This could be explained by the fact that WAT, in contrast to
BAT, is less dense innervated by the sympathetic nervous system
and thus probably less dependent on its activation [2]. In addition,
UCP-1 expression might be differentially regulated in bright cells
compared to the brown adipocytes present in the brown fat pads.
Brite cells have been suggested to contribute importantly to total
energy expenditure, as these cells are more abundant in obesity-
resistant strains of mice [33,34]. In our study, mice that were
treated with BMP7 at 28uC displayed an increase of brite fat cells
without activating brown fat pads. This was however not sufficient
to raise total energy expenditure. Interestingly, the recently
indentified hormone irisin, which is released from muscle after
exercise, selectively induced browning of subcutaneous WAT
depots, without affecting differentiation or activity of brown fat
pads, and did lead to an increase in total energy expenditure [20].
In conclusion, BMP7 stimulates BAT volume, activity and total
energy expenditure only at subthermoneutrality, suggesting that
intact sympathetic activation is a prerequisite for the effects of
BMP7 on BAT. Furthermore, we found that BMP7 diminishes
obesity and liver lipid accumulation, and attenuates dyslipidemia
and hyperglycemia in diet-induced obese mice. We anticipate that
BAT may be a promising novel treatment goal, and BMP7 a
treatment modality, in fighting obesity and related disorders.
Supporting Information
Figure S1 BMP7 does not affect energy expenditure, fat
oxidation, food intake and weight development at thermoneu-
trality. 4-week-old male C57Bl/6J mice were treated for 4 weeks
with BMP7 (33 or 100 mg/kg/day) or saline via a subcutaneously
located osmotic minipumps at an environmental temperature of
21uC or 28uC while feeding a high-fat diet (45% fat). (A) Energy
expenditure, fat and carbohydrate oxidation and activity levels
measured during 5 consecutive days in the fourth week of
treatment via fully automatic metabolic cages in mice housed at
28uC. Measurements were corrected for free fat mass (FFM). (B)
Food intake measured during the fourth week of treatment in mice
housed at 28uC. (C) Body weight (gram) development during
treatment at 28uC. Values are means+SEM (n = 9).
(TIF)
Figure S2 BMP7 does not affect weight development but
increases bone mineral content at 21uC. 4-week-old male
C57Bl/6J mice were treated for 4 weeks with BMP7 (33 or
100 mg/kg/day) or saline via a subcutaneously located osmotic
minipumps at an environmental temperature of 21uC or 28uC
while feeding a high-fat diet (45% energy). (A) Body weight
development (gram) during treatment at 21uC (B) Bone mineral
content as measured via DEXA scan after 4 weeks of treatment at
21uC. Values are means+SEM (n = 9) *P,0.05 compared to the
control group.
(TIF)
Figure S3 BMP7 alters the M1/M2 balance in WAT at 21uC,
but not at thermoneutrality. 4-week-old male C57Bl/6J mice were
treated for 4 weeks with BMP7 (33 or 100 mg/kg/day) or saline via
a subcutaneously located osmotic minipump at an environmental
temperature of 21uC or 28uC while feeding a high-fat diet (45%
energy). (A–B) Expression of the M2 markers Mrc1 (A) and Cd163
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(B) in gWAT measured by Q-RT-PCR of mice housed at 21uC
(left) or 28uC (right). (C) Expression of the M1 marker Nos2 in
gWAT measured by Q-RT-PCR of mice housed at 21uC (left) or
28uC (right). Values are means+SEM (n = 9) and expression of
genes was corrected for the housekeeping genes b2-microglobulin
and 36b4. *P,0.05 compared to the control group.
(TIF)
Figure S4 BMP7 does not alter cytokine secretion by bone-
marrow derived macrophages. Bone-marrow derived macrophag-
es were isolated from untreated male C57BL6/J mice, plated in a
24-well plate (106 cells/mL) and stimulated with BMP7 (8.3 nM)
or vehicle for 24 hours or with BMP7 (8.3 nM) or vehicle for 18
hours +6 hours LPS (10 ng/mL). The concentration of IL-6 (A),
TNF (B), NO2
- (C) and IL-12 (D) in the supernatant was
measured. Values are means+SEM (n = 3).
(TIF)
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